Abstract
Purpose : To calculate the added benefit of a cryopreservation program to the cumulative ongoing pregnancy rate over a maximum of three cycles of IVF.
Methods : A total of 1251 couples beginning their first IVF treatment between January 1995 and December 1999 were evaluated. Ongoing pregnancies from fresh and subsequent cryopreserved embryo transfer cycles were analyzed. Pregnancies arising from the cryopreservation cycle were considered to augment the cumulative pregnancy rate when no ongoing pregnancy arose from the fresh embryo transfer cycle.
Results : The ongoing pregnancy rate per cryopreserved embryo transfer was 11.7%. The cumulative ongoing pregnancy rate following three successive started fresh IVF cycles was 42.5%. When pregnancies arising from the transfer of thawed cryopreserved embryos were included, the cumulative ongoing pregnancy rate increased to 43.8%, rising to 44.8% when extrapolated data from as yet unthawed embryos was included.
Conclusions : When analyzed in these terms, the supplementary benefit of cryopreserving supranumerical embryos appears limited.
Similar content being viewed by others
REFERENCES
Trounson A, Mohr L: Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 1983;305:707–709
Zeilmaker GH, Alberda AT, van Gent I, Rijkmans CM, Drogendijk AC: Two pregnancies following transfer of intact frozen–thawed embryos. Fertil Steril 1984;42:293–296
The American Fertility Society: Revised minimum standards for in vitro fertilization, gamete intrafallopian transfer, and related procedures. Fertil Steril 1990;53:225–226
Fugger EF: Clinical status of human embryo cryopreservation in the United States of America. Fertil Steril 1989;52:986–990
Quigley MM, Wolf DP, Maklad NF, Dandekar PV, Sokoloski JE: Follicular size and number in human in vitro fertilization. Fertil Steril 1982;38:678–681
MacDougall MJ, Tan SL, Hall V, Balen A, Mason BA, Jacobs HS: Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: A prospective, randomized trial. Fertil Steril 1994;61:1052–1057
Tan SL, Kingsland C, Campbell S, Mills C, Bradfield J, Alexander N, Yovich J, Jacobs HS: The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810–814
Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van deKoppel P, Collins JA: The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888–896
Schieve LA, Peterson HB, Meikle SF, Jeng G, Danel I, Burnett NM, Wilcox LS: Live-birth rates and multiple-birth risk using in vitro fertilization. JAMA 1999;282:1832–1838
Mandelbaum J, Belaisch-Allart J, Junca AM, Antoine JM, Plachot M, Alvarez S, Alnot MO, Salat-Baroux J: Cryopreservation in human assisted reproduction is now routine for embryos but remains a research procedure for oocytes. Hum Reprod 1998;13(Suppl 3):161–174
Edwards RG, Lobo R, Bouchard P: Time to revolutionize ovarian stimulation. Hum Reprod 1996;11:917–919
Olivennes F, Frydman R: Friendly IVF: The way of the future? Hum Reprod 1998;13:1121–1124
Fauser BC, Devroey P, Yen SS, Gosden R, Crowley WF Jr, Baird DT, Bouchard P: Minimal ovarian stimulation for IVF: Appraisal of potential benefits and drawbacks. Hum Reprod 1999;14:2681–2686
De Vries MJ, De Sutter P, Dhont M: Prognostic factors in patients continuing in vitro fertilization or intracytoplasmic sperm injection treatment and dropouts. Fertil Steril 1999;72:674–678
Osmanagaoglu K, Tournaye H, Camus M, Vandervorst M, Van Steirteghem A, Devroey P: Cumulative delivery rates after intracytoplasmic sperm injection: 5 year follow-up of 498 patients. Hum Reprod 1999;14:2651–2655
Schenker JG: Assisted reproduction practice in Europe: Legal and ethical aspects. Hum Reprod Update 1997;3:173–184
Fasouliotis SJ, Schenker JG: Cryopreservation of embryos: Medical, ethical, and legal issues. J Assist Reprod Genet 1996;13:756–761
Jones HWJ, Veeck LL, Muasher SJ: Cryopreservation: The problem of evaluation. Hum Reprod 1995;10:2136–2138
Van der Elst J, Camus M, Van den Abbeel E, Maes R, Devroey P, Van Steirteghem AC: Prospective randomized study on the cryopreservation of human embryos with dimethylsulfoxide or 1,2-propanediol protocols. Fertil Steril 1995;63:92–100
Van Steirteghem AC, Van der Elst J, Van den Abbeel E, Joris H, Camus M, Devroey P: Cryopreservation of supernumerary multicellular human embryos obtained after intracytoplasmic sperm injection. Fertil Steril 1994;62:775–780
Macklon NS, Pieters MH, Fauser BCJM: Indications for IVF treatment: from diagnosis to prognosis. In Textbook of Assisted Reproductive Techniques, DK Gardner, A Weissman, CM Howles, Z Shoham (eds), London, Martin Dunitz, 2001,pp 393–400.
Huisman GJ, Fauser BC, Eijkemans MJ, Pieters MH: Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture. Fertil Steril 2000;73:117–122
Hunault CC, Eijkemans MJ, Pieters MH, te Velde ER, Habbema JD, Fauser BC, Macklon NS:Aprediction model for selecting patients for elective single embryo transfer in IVF. Fertil Steril 2002;77:725–732
Veeck LL: Preembryo grading and degree of cytoplasmic fragmentation. In An Atlas of Human Gametes and Conceptuses, LL Veeck (ed), New York, Parthenon Publishing, 1998, pp 40–45.
Jones HWJ, Jones D, Kolm P: Cryopreservation: A simplified method of evaluation. Hum Reprod 1997;12:548–553
Muenz LR, Rubinstein LV: Markov models for covariate dependence of binary sequences. Biometrics 1985;41:91–101
The ganirelix dose-finding study group: A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum Reprod 1998;13:3023–3031
The European Orgalutran Study group, BormG, Mannaerts B: Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial. Hum Reprod 2000;15:1490–1498
The European IVF-monitoring programme (EIM), Nygren K, Nyboe Andersen A for the European Society of Human Reproduction and Embryology (ESHRE): Assisted reproductive technology in Europe, 1997. Results generated from European registers by ESHRE. Hum Reprod 2001;16:384–391
Ludwig M, Al-Hasani S, Felberbaum R, Diedrich K: No impact of cryopreservation on embryo development potential—one more example of the problems of retrospective, non-controlled data. Hum Reprod 1998;13:786–787
Testart J: Episcientific aspects of the epigenetic factors in arti-ficial procreation. Hum Reprod 1998;13:783–785
Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine: Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2000;74:641–654
Van den Abbeel E, Van Steirteghem A: Zona pellucida damage to human embryos after cryopreservation and the consequences for their blastomere survival and in-vitro viability. Hum Reprod 2000;15:373–378
Jones HWJ, Out HJ, Hoomans EH, Driessen SG, Coelingh Bennink HJ: Cryopreservation: The practicalities of evaluation. Hum Reprod 1997;12:1522–1524
Van der Elst J, Van den Abbeel E, Camus M, Smitz J, Devroey P, Van Steirteghem A: Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG. Hum Reprod 1996;11:2097–2106
Edgar DH, Bourne H, Spiers AL, McBain JC: A quantative analysis of the impact of cryopreservation on the implantation potential of human early cleavage stage embryos.HumReprod 2000;15:175–179
Fauser BC, Bouchard P, Coelingh Bennink HJ, Collins JA, Devroey P, Evers JL, Van Steirteghem A: Alternative approaches in IVF. Hum Reprod Update 2002;8:1–9
Troup SA, Matson PL, Critchlow JD, Morroll DR, Lieberman BA, Burslem RW: Cryopreservation of human embryos at the pronucleate, early cleavage, or expanded blastocyst stages. Eur J Obstet Gynecol Reprod Biol 1991;38:133–139
Kaufman RA, Menezo Y, Hazout A, Nicollet B, DuMont Mm, Servy EJ: Cocultured blastocyst cryopreservation: Experience of more than 500 transfer cycles. Fertil Steril 1995;64:1125–1129
Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine: Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2002;77:18–31
Eugster A, Vingerhoets AJ: Psychological aspects of in vitro fertilization: A review. Soc Sci Med 1999;48:575–589
Shannon TA: Ethical issues involved with in vitro fertilization. AORN J 1990;52:627–631
de Jong D, Macklon NS, Fauser BC: A pilot study involving minimal ovarian stimulation for in vitro fertilization: Extending the “follicle-stimulating hormone window” combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril 2000;73:1051–1054
Macklon NS, Fauser BCJM: Alternative approaches to ovarian stimulation for IVF. Reprod Med Rev 2001;9:77–89
Hojgaard A, Ingerslev HJ, Dinesen: Friendly IVF: Patient opinions. Hum Reprod 2001;16:1391–1396
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Jong, D., Eijkemans, M.J.C., Beckers, N.G.M. et al. The Added Value of Embryo Cryopreservation to Cumulative Ongoing Pregnancy Rates Per IVF Treatment: Is Cryopreservation Worth the Effort?. J Assist Reprod Genet 19, 561–568 (2002). https://doi.org/10.1023/A:1021211115337
Issue Date:
DOI: https://doi.org/10.1023/A:1021211115337